Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celsion Receives European Orphan Drug Designation for ThermoDox(R) to Treat Primary Liver Cancer
Celsion Receives European Orphan Drug Designation for ThermoDox(R) to Treat Primary Liver Cancer
Celsion Receives European Orphan Drug Designation for ThermoDox(R) to Treat Primary Liver Cancer
Submitted by
moderatora
on March 2, 2011 - 5:09pm
Source:
Yahoo/Marketwire
News Tags:
Celsion
Europe
ThermoDox
liver cancer
Headline:
Celsion Receives European Orphan Drug Designation for ThermoDox(R) to Treat Primary Liver Cancer
Do Not Allow Advertisers to Use My Personal information
